39 results
8-K
EX-3.1
ALIM
Alimera Sciences Inc.
15 Aug 23
Unregistered Sales of Equity Securities
4:55pm
8-K
EX-3.1
ALIM
Alimera Sciences Inc.
2 Aug 23
Unregistered Sales of Equity Securities
5:18pm
8-K
EX-3.1
ALIM
Alimera Sciences Inc.
18 May 23
Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023
4:55pm
DEFA14A
EX-3.2
ALIM
Alimera Sciences Inc.
27 Mar 23
Additional proxy soliciting materials
10:12am
DEFA14A
EX-3.3
ALIM
Alimera Sciences Inc.
27 Mar 23
Additional proxy soliciting materials
10:12am
DEFA14A
EX-3.1
tchxrim5srqobwxvf
27 Mar 23
Additional proxy soliciting materials
10:12am
8-K
EX-3.1
rs8flhl2r2sn3vw
27 Mar 23
Alimera Improves Capital Structure, Strengthens Balance Sheet and Extends Term Loan Facility
10:06am
8-K
EX-3.2
t4np9k4e5qk1r448g
27 Mar 23
Alimera Improves Capital Structure, Strengthens Balance Sheet and Extends Term Loan Facility
10:06am
8-K
EX-3.3
iynutp pohp
27 Mar 23
Alimera Improves Capital Structure, Strengthens Balance Sheet and Extends Term Loan Facility
10:06am
8-K
EX-3.2
3qyd06fje9o0 mmg
14 Nov 19
Alimera Sciences Announces Effectiveness
5:02pm
8-K
EX-3.3
ch9gn87y
16 Sep 19
Amendments to Articles of Incorporation or Bylaws
5:25pm
8-K
EX-3.1
mjdfk 2gk
5 Sep 18
Alimera Sciences Announces Exchange of Series B Preferred Stock for Newly Issued Series C Preferred Stock
12:00am
8-K
EX-3.2
0lx1wq8nbtaxv88
5 Sep 18
Alimera Sciences Announces Exchange of Series B Preferred Stock for Newly Issued Series C Preferred Stock
12:00am
8-K
EX-3.1
28ejurxjua1utw8 az04
5 Nov 15
Alimera Sciences Reports Third Quarter 2015 Financial Results
12:00am
8-K
EX-3.6
j8qrbzzpnpfa7d7y
15 Dec 14
Alimera Sciences Announces Closing of $50.0 Million Financing with Deerfield Management
12:00am
8-K
EX-3.6
e45u9c881clelrhd h2
28 Nov 14
Alimera Sciences Announces Agreement with Deerfield Management
12:00am